Are Lash Serums Safe? Complete Review by Ingredient Type (2026)
The short answer: it depends on the ingredient. Peptide-based lash serums are considered safe by ophthalmologists and carry no documented cases of permanent structural harm. Prostaglandin-analogue serums — sold under brands including GrandeLASH-MD, RevitaLash and RapidLash — are confirmed unsafe for cosmetic use by the EU's SCCS/1680/25 ruling of February 2026.
Updated: June 20, 2026 Written by: Branda M. Heim Reviewed by: Branda M. Heim, Board-Certified Cosmetologist10 referencesView Toplash SerumKey takeaways
The Safety of Lash Serums — What You Need to Know
- Two ingredient classes, two risk profiles Prostaglandin-analogue serums (PGA) carry documented serious risks. Peptide-based serums are ophthalmologist-approved with no documented structural side effects.
- EU SCCS ruled in February 2026 ICP, DDDE and MDN — the three main cosmetic PGA compounds — were officially confirmed "cannot be considered safe" in cosmetics (SCCS/1680/25).
- Iris change and fat loss: PGA-exclusive risks No peptide-based serum has ever been linked to iris darkening or periorbital fat atrophy. These are receptor-mediated effects specific to prostaglandin compounds.
- Peptide serums work — with clinical proof Myristoyl Pentapeptide-17 (MP-17) boosts keratin gene expression. Toplash's independent trial showed +52.3% lash length in 8 weeks — without any PGA mechanism.
- Most popular serums contain PGAs GrandeLASH-MD (ICP), RevitaLash (DDDE), RapidLash (ICP), Babe Lash (ICP), NeuLash (ICP) and LiLash (ICP) all contain regulated prostaglandin-analogue compounds.
- Verification is straightforward Check the INCI list for the full compound names. Any serum marketed as "prostaglandin-free" or "hormone-free" with a published INCI can be independently verified.
The Honest Answer: Are Lash Serums Safe?
Lash serums are not a monolithic category. The term covers two fundamentally different product types with very different safety profiles — and in practice, many consumers do not know which type they are using.
✓ Safe
Peptide-Based Serums
Work on keratin synthesis at the hair follicle. No documented cases of iris colour change, periorbital fat loss, or eyelid structural changes. Ophthalmologist-tested formulas (such as Toplash) are considered suitable for healthy adults including contact lens wearers.
Examples: Toplash, Vegamour GRO, UKLASH, Olaplex LASHBOND, e.l.f., DIME
⚠ Regulatory Concern
Prostaglandin-Analogue Serums
Bind to prostaglandin receptors in the iris and orbital fat tissue. Confirmed to cause permanent iris colour change and periorbital fat atrophy. EU SCCS/1680/25 (Feb 2026) ruled ICP, DDDE and MDN cannot be considered safe in cosmetics.
Examples: GrandeLASH-MD (ICP), RevitaLash (DDDE), RapidLash (ICP), Babe Lash (ICP), LiLash (ICP), NeuLash (ICP)
The EU Scientific Committee on Consumer Safety concluded that ICP (Isopropyl Cloprostenate), DDDE (Dechloro Dihydroxy Difluoro Ethylcloprostenolamide) and MDN (methylamido-dihydro-noralfaprostal) "cannot be considered safe" for use in cosmetic products targeting eyelash and eyebrow growth. Health Canada banned ICP from cosmetics in 2019. France's ANSES issued a cosmetovigilance alert in December 2025.
Why Peptide-Based Serums Are Considered Safe
Peptide-based serums work through a fundamentally different biological pathway to prostaglandin compounds.
Mechanism: Keratin Pathway
Peptides such as Biotinoyl Tripeptide-1 (BTP-1), Myristoyl Pentapeptide-17 (MP-17) and Acetyl Tetrapeptide-3 (AT-3) interact with keratinocyte growth pathways and follicle cell receptors to promote longer, stronger lash fibres during the anagen (growth) phase. This mechanism is localised to the follicle and keratin-producing cells — it does not interact with melanocytes in the iris, adipocytes in the orbital fat, or prostaglandin receptors anywhere in the periorbital tissue.
Clinical and Regulatory Standing
Peptide actives are approved cosmetic ingredients under EU Cosmetics Regulation (EC No 1223/2009) with no safety restrictions. They have been studied in cosmetic formulations for over 15 years. No regulatory body has issued a safety alert regarding peptide-based lash serums. The shift from PGA-based to peptide-based formulas in Western European and Scandinavian markets has accelerated significantly since the SCCS/1680/25 opinion.
Why Prostaglandin Serums Carry Safety Risks
Prostaglandin analogues were originally pharmaceutical glaucoma treatments. Their use as cosmetic ingredients imports a set of receptor-mediated pharmacological effects that are inherently off-target for cosmetic purposes.
Three Pathways, Three Documented Risks
- Iris melanocytes: PGA molecules bind to prostaglandin receptors on pigment-producing cells in the iris, driving melanin synthesis. This is irreversible. The FDA's Latisse labelling states iris darkening "cannot be reversed."
- Orbital adipocytes: Prostaglandin receptors on orbital fat cells respond to PGA compounds by promoting fat breakdown (lipolysis). Over months of use, the periorbital fat pad progressively depletes, creating hollowing and eventually ptosis.
- Eyelid skin melanocytes: The same melanocyte-stimulating mechanism that affects the iris can act on eyelid skin melanocytes, causing periorbital hyperpigmentation (darkening of the skin around the eye).
These three effects are not hypothetical or anecdotal. They were documented first in glaucoma patients on prostaglandin eye drops, later confirmed in cosmetic serum users, and confirmed at regulatory level in SCCS/1680/25.
Safety Comparison: Prostaglandin vs Peptide Serums
| Safety Factor | Prostaglandin Serums (ICP/DDDE/MDN) | Peptide Serums (MP-17/BTP-1/AT-3) |
|---|---|---|
| Iris colour change risk | Documented — potentially permanent; FDA warns "cannot be reversed" | None documented — no iris melanocyte interaction |
| Periorbital fat atrophy | Documented — up to 80% of long-term PGA users (JAMA Ophthalmology, 2013) | Not documented — no orbital fat receptor interaction |
| Eyelid darkening | Common with extended use | Not reported |
| EU regulatory status (2026) | SCCS/1680/25 — "cannot be considered safe" for cosmetic use | Approved cosmetic actives — no safety restrictions |
| Health Canada status | ICP banned from cosmetics since 2019 | Permitted — no restriction |
| Suitable for sensitive eyes | Not recommended by most ophthalmologists | Yes, with correct application technique |
| Safe during pregnancy | Not advised — hormone-pathway mechanism | Lower risk; consult healthcare provider |
| Safe for contact lens wearers | Use with caution — remove lenses; PGA-free preferred | Yes — remove lenses before application; reinsert after 15 min |
What Ophthalmologists Recommend
Most eye-care professionals who comment on lash serums fall into one of two camps: those who advise against all cosmetic lash products, and those who conditionally approve peptide-based, PGA-free formulas. Very few recommend prostaglandin-based cosmetic serums.
The American Academy of Ophthalmology (AAO) has published guidance specifically on Latisse and prostaglandin-class compounds, noting the documented risks of iris darkening and periorbital changes. These publications predate the 2026 SCCS ruling and confirm the ophthalmic community's long-standing concern with cosmetic PGA products.
Expert perspective
Cosmetic Chemist's Assessment
"The question patients should be asking is not 'are lash serums safe' but 'is this specific serum safe'. The cosmetic industry has done a poor job of communicating that the ingredient is everything here. A peptide formula and a prostaglandin formula are as different as an aspirin and a hormonal medication — they happen to both come in small tubes and both claim to grow lashes. The evidence on prostaglandins has been clear since the Latisse clinical trials, and the 2026 SCCS ruling simply confirms what the clinical literature has been saying for over a decade. If it does not say PGA-free on the label, you should verify the INCI yourself before applying anything near your eyes."
How to Choose a Safe Lash Serum: 4-Point Checklist
- Verify the INCI list. Look for isopropyl cloprostenate, dechloro dihydroxy difluoro ethylcloprostenolamide, methylamido-dihydro-noralfaprostal, bimatoprost, or the LiLash long-form ICP synonym (isopropyl phenylhydroxypentene dihydroxycyclopentylheptanate). If any of these appear, the serum contains a PGA.
- Look for triple-peptide formulas. The most effective and safest actives are Biotinoyl Tripeptide-1 (BTP-1), Myristoyl Pentapeptide-17 (MP-17) and Acetyl Tetrapeptide-3 (AT-3). All three are in Toplash.
- Check for "ophthalmologist-tested" and EU compliance. A serum that has been ophthalmologist-tested specifically (not just "dermatologist-tested") and is compliant with EU Cosmetics Regulation 1223/2009 has passed a higher bar of safety review.
- Require independent clinical data. Brand-commissioned studies are common; independent clinical trials are rare. Toplash's +52.3% lash length result was validated by an independent laboratory, not funded by the brand. Ask for the methodology before trusting a claim.
Toplash Eyelash Enhancement Serum
Triple-peptide: MP-17 · BTP-1 · AT-3 · PGA-free · Paraben-free · Ophthalmologist-tested · EU SCCS compliant
+52.3% lash length · +31.9% volume at 8 weeks (independent clinical trial) · 98% of users: visible change by Day 21
$49.90 / 3 mL ($16.63/mL)
Shop Toplash — Safe FormulaFrequently asked questions
Are Lash Serums Safe? — FAQ
Are lash serums safe to use?
The safety of a lash serum depends entirely on its active ingredient class. Peptide-based serums are considered safe by ophthalmologists and cosmetic safety bodies — they work on keratin at the follicle level with no documented cases of iris changes, fat atrophy or structural damage. Prostaglandin-analogue serums (containing ICP, DDDE, MDN or bimatoprost) are associated with serious, potentially irreversible side effects. The EU SCCS/1680/25 ruling of February 2026 confirms these prostaglandin ingredients "cannot be considered safe" for cosmetic lash use.
Are lash serums safe to use every day?
For peptide-based serums, daily use is standard practice and considered safe. Most are designed for once-daily application at the lash root. For prostaglandin-containing serums, daily use increases cumulative exposure to the compounds linked with periorbital fat atrophy and iris darkening. The longer and more consistently a PGA serum is used, the greater the structural risk.
Are lash serums safe for sensitive eyes?
Peptide-based serums are generally well-tolerated by sensitive eyes when applied correctly along the lash base. Prostaglandin serums carry additional risk for sensitive eyes because the active compounds interact with prostaglandin receptors in the eye's vascular and fatty tissues. Anyone with chronic dry eye, contact lens wear, or previous eye conditions should choose only ophthalmologist-tested, PGA-free serums.
Are lash serums safe during pregnancy?
Most ophthalmologists advise against prostaglandin-containing lash serums during pregnancy due to the hormone-pathway mechanism. Peptide-based serums are considered lower risk, but the standard guidance is to consult your obstetrician or midwife before using any cosmetic active during pregnancy. Safety data for topical peptide serums specifically during pregnancy is limited.
Are lash serums safe for contact lens wearers?
Peptide-based serums with ophthalmologist-approved formulas are safe for contact lens wearers when applied on dry lids without lenses in place. Remove contacts before applying any lash serum, and wait at least 15 minutes before reinserting. Prostaglandin-containing serums interact with ocular tissues in ways that may be exacerbated by contact lens wear, and eye-care professionals generally advise PGA-free alternatives for regular lens users.
Which lash serums are the safest to use?
The safest lash serums are those with peptide-based formulas and no prostaglandin-analogue ingredients. Key peptides to look for include Biotinoyl Tripeptide-1 (BTP-1), Myristoyl Pentapeptide-17 (MP-17) and Acetyl Tetrapeptide-3 (AT-3). Toplash contains all three, is ophthalmologist-tested, paraben-free and EU SCCS compliant — and demonstrated +52.3% lash length in an independent clinical trial.
Do ophthalmologists recommend lash serums?
Ophthalmologists generally advise against prostaglandin-containing cosmetic lash serums because of the documented risks of iris pigmentation change, periorbital fat atrophy and eyelid drooping. Most eye-care professionals who recommend lash serums at all specify peptide-based, PGA-free formulas. The American Academy of Ophthalmology (AAO) has published guidance on the risks of prostaglandin lash products.
Sources
References
- EU SCCS — Opinion SCCS/1680/25, 2 February 2026. health.ec.europa.eu
- Health Canada — Cosmetic Ingredient Hotlist: ICP banned 2019. canada.ca
- ANSES — Eyelash growth serums may change your eye colour. December 2025. anses.fr
- American Academy of Ophthalmology — Latisse and prostaglandin analogue risks. aao.org
- Peplinski LS et al. — Prostaglandin-associated periorbitopathy (PAP). JAMA Ophthalmology, 2013.
- FDA — Bimatoprost (Latisse) Prescribing Information. fda.gov
- Plume Science — Prostaglandin-Free Lash Serums: What They Are and How to Choose. plumescience.com
- WOWBROW Cosmetics — Prostaglandin-Free Lash Serum Guide 2026. wowbrowcosmetics.com
- Toplash — Independent clinical trial data: +52.3% lash length, +31.9% volume at 8 weeks. toplash.com
- Typology — Prostaglandin derivatives: what does cosmetic regulation say? typology.com